Redeye retains its positive view of CombinedX following a strong Q1 both in terms of growth and margins. While the soft Q2 guidance might dampen the share short-term, considering CombinedX's recent performance, we believe the discount to peers will decline going forward. We leave our Base Case unchanged and raise our forecasts slightly.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

CombinedX - Impressive Q1 but Soft Guidance for Q2

© Modular Finance, source Nordic Press Releases